News

2025’s Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence

25 EHR Vendors Recognized Across 40 Physician Specialties, with ModMed, NextGen, Netsmart, ClinicMind, Epic, and RXNT Leading in Multiple Categories…

12 months ago

DirectTrust(R) Announces 2025 Accreditation Criteria Versions for All Accreditation Programs

Updates for 2025 include new Digital Therapeutic program criteria, new HIPAA and Maryland reproductive health regulations, FTC breach reporting rules,…

12 months ago

Hemostemix is Up-Listing in the USA to Generate Liquidity

Calgary, Alberta--(Newsfile Corp. - January 2, 2025) -   Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

12 months ago

DentalXChange and Open Dental Announce Transformative XConnect Integration

DentalXChange and Open Dental are excited to announce the integration of DentalXChange’s XConnect™ Claims validation API. IRVINE, CALIFORNIA / ACCESSWIRE…

12 months ago

Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories

BOSTON, MA / ACCESSWIRE / January 2, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc.…

12 months ago

Avenues Announces Ribbon-Cutting and Open House of New South Bend Facility

SOUTH BEND, INDIANA / ACCESSWIRE / January 2, 2025 / Avenues Recovery Center announced today the ribbon-cutting ceremony and open…

12 months ago

NeoPredics Announces Prof. Stefan Verlohren as Chairman of Medical and Scientific Advisory Board

FORT LAUDERDALE, FLORIDA / ACCESSWIRE / January 2, 2025 / NeoPredics AG Switzerland, together with its subsidiaries NeoPredics AG Germany…

12 months ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of…

12 months ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing…

12 months ago

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health…

12 months ago